The impact of admission procalcitonin on prognosis in acute coronary syndromes: a pilot study

References

• Ataoglu HE, Yilmaz F, Uzunhasan I, Cetin F, Temiz L, Döventas YE, Kaya A, Yenigün M. (2010). Procalcitonin: a novel cardiac marker with prognostic value in acute coronary syndrome. J Int Med Res 38:52–61.
   PubMed Web of Science ®Google Scholar
• Biasucci LM, Biasillo G, Stefanelli A. (2009). Procalcitonin and acute coronary syndromes: a new biomarker for an old disease. Intern Emerg Med 4:363–365.
   PubMed Web of Science ®Google Scholar
• Buratti T, Ricevuti G, Pechlaner C, Joannidis M, Wiedermann FJ, Gritti D, Herold M, Wiedermann CJ. (2001). Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction. Inflammation 25:97–100.
   PubMed Web of Science ®Google Scholar
• Califf RM, Bengtson JR. (1994). Cardiogenic shock. N Engl J Med 330:1724–1730.
   PubMed Web of Science ®Google Scholar
• Geppert A, Steiner A, Delle-Karth G, Heinz G, Huber K. (2003). Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock. Intensive Care Med 29:1384–1389.
   PubMed Web of Science ®Google Scholar
• Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D, Bax JJ, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Torbicki A, Vahanian A, Windecker S, Windecker S, Achenbach S, Badimon L, Bertrand M, Bøtker HE, Collet JP, Crea F, Danchin N, Falk E, Goudevenos J, Gulba D, Hambrecht R, Herrmann J, Kastrati A, Kjeldsen K, Kristensen SD, Lancellotti P, Mehilli J, Merkely B, Montalescot G, Neumann FJ, Neyses L, Perk J, Roffi M, Romeo F, Ruda M, Swahn E, Valgimigli M, Vrints CJ, Widimsky P; Authors/Task Force Members; ESC Committee for Practice Guidelines; Document Reviewers. (2011). ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. (In Press).
   Google Scholar
• Hochman JS. (2003). Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 107:2998–3002.
   PubMed Web of Science ®Google Scholar
• Kafkas N, Venetsanou K, Patsilinakos S, Voudris V, Antonatos D, Kelesidis K, Baltopoulos G, Maniatis P, Cokkinos DV. (2008). Procalcitonin in acute myocardial infarction. Acute Card Care 10:30–36.
   PubMedGoogle Scholar
• Kelly D, Khan SQ, Dhillon O, Quinn P, Struck J, Squire IB, Davies JE, Ng LL. (2010). Procalcitonin as a prognostic marker in patients with acute myocardial infarction. Biomarkers 15:325–331.
   PubMed Web of Science ®Google Scholar
• Lazzeri C, Bonizzoli M, Cianchi G, Gensini GF, Peris A. (2008). Troponin I in the intensive care unit setting: from the heart to the heart. Intern Emerg Med 3:9–16.
   PubMed Web of Science ®Google Scholar
• Lazzeri C, Sori A, Chiostri M, Gensini GF, Valente S. (2009). Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention. Eur J Anaesthesiol 26:856–862.
   PubMed Web of Science ®Google Scholar
• Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF. (2010a). Microalbuminuria in hypertensive nondiabetic patients with ST elevation myocardial infarction. J Cardiovasc Med (Hagerstown) 11:748–753.
   PubMed Web of Science ®Google Scholar
• Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2011a) Acute glucose dysmetabolism in the elderly with ST elevation myocardial infarction submitted to mechanical revascularization. Int J Cardiol Feb 21. [Epub ahead of print]
   Google Scholar
• Lazzeri C, Valente S, Chiostri M, Sori A, Bernardo P, Gensini GF. (2010b). Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience. Int J Cardiol 138:206–209.
   PubMed Web of Science ®Google Scholar
• Lazzeri C, Valente S, Tarquini R, Chiostri M, Picariello C, Gensini GF. (2010c). Prognostic values of admission transaminases in ST-elevation myocardial infarction submitted to primary angioplasty. Med Sci Monit 16:CR567–CR574.
   Google Scholar
• Lazzeri C, Valente S, Tarquini R, Chiostri M, Picariello C, Gensini GF. (2011b). The prognostic role of gamma-glutamyltransferase activity in non-diabetic ST-elevation myocardial infarction. Intern Emerg Med 6:213–219.
   Google Scholar
• Picariello C, Lazzeri C, Chiostri M, Gensini G, Valente S. (2009). Procalcitonin in patients with acute coronary syndromes and cardiogenic shock submitted to percutaneous coronary intervention. Intern Emerg Med 4:403–408.
   PubMed Web of Science ®Google Scholar
• Picariello C, Lazzeri C, Valente S, Chiostri M, Attanà P, Gensini GF. (2010). Kinetics of procalcitonin in cardiogenic shock and in septic shock. Preliminary data. Acute Card Care 12:96–101.
   PubMedGoogle Scholar
• Remskar M, Horvat M, Hojker S, Noc M. (2002). Procalcitonin in patients with acute myocardial infarction. Wien Klin Wochenschr 114:205–210.
   PubMed Web of Science ®Google Scholar
• Sentürk T. (2011). Measurement of procalcitonin in acute coronary syndrome. – Yet another prognostic biomarker?-. Circ J 75:1059–1060.
   Google Scholar
• Sentürk T, Cordan J, Baran I, Ozdemir B, Güllülü S, Aydinlar A, Göral G. (2007). Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease. Acta Cardiol 62:135–141.
   PubMed Web of Science ®Google Scholar
• Sinning CR, Sinning JM, Schulz A, Schnabel RB, Lubos E, Wild PS, Papassotiriou J, Bergmann A, Blankenberg S, Munzel T, Bickel C; AtheroGene Study Investigators. (2011). Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease. Circ J 75:1184–1191.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. (2007). Universal definition of myocardial infarction. J Am Coll Cardiol 50:2173–2195.
   PubMed Web of Science ®Google Scholar
• Valente S, Lazzeri C, Chiostri M, Giglioli C, Sori A, Tigli S, Gensini GF. (2009). NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers. Int J Cardiol 132:84–89.
   PubMed Web of Science ®Google Scholar
• Valente S, Lazzeri C, Chiostri M, Sori A, Giglioli C, Salvadori C, Gensini GF. (2008). Time of onset and outcome of cardiogenic shock in acute coronary syndromes. J Cardiovasc Med (Hagerstown) 9:1235–1240.
   PubMed Web of Science ®Google Scholar
• Webb JG, Lowe AM, Sanborn TA, White HD, Sleeper LA, Carere RG, Buller CE, Wong SC, Boland J, Dzavik V, Porway M, Pate G, Bergman G, Hochman JS; SHOCK Investigators. (2003). Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol 42:1380–1386.
   PubMed Web of Science ®Google Scholar